May Kung Sutherland

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

Leia M. Smith, Albina Nesterova, Maureen C. Ryan et al. · British Journal of Cancer · 2008 · 285 citations · Full text

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

May Kung Sutherland, James C. Geoghegan, Changpu Yu et al. · Bone · 2004 · 236 citations

Tissue Engineering, Sclerostin, Bone Morphogenic Protein +12

Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels

May Kung Sutherland, Martin J. Somerville, Larry K.K. Yoong et al. · Molecular Brain Research · 1992 · 196 citations

Alzheimer's Disease, Medicine, Dementia +10

Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex

David G. Winkler, Changpu Yu, James C. Geoghegan et al. · Journal of Biological Chemistry · 2004 · 105 citations · Full text

Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia

Fu Li, May Kung Sutherland, Changpu Yu et al. · Molecular Cancer Therapeutics · 2017 · 94 citations